With Duane Lakings October 29th in our Live Streamed Classroom - Register Now!
Next Course Date
October 29 - November 1, 2024 12:00 to 5:00 ET / 9:00 to 2:00 PT |
|
|
| Duane B. Lakings, Ph.D., is the Principal and President of Drug Safety Evaluation Consulting, Inc. DSE Consulting assists pharmaceutical and biotechnology companies in designing, conducting, and interpreting results from experiments for characterizing and developing drug candidates into therapeutic products. Dr. Lakings has over 25 years of experience in drug discovery and developability assessment, preclinical and nonclinical development, and clinical development and has designed and conducted animal and human research studies on both small organic molecules and macromolecules. |
|
|
Course runs 12:00 to 5:00 ET / 9:00 to 2:00 PT This pharmaceutical manufacturing training course will assist pharmaceutical, biotechnology, and CRO researchers and managers in understanding the requirements for a well-designed and successful ADME, PK/TK, and DM program conducted within a drug development logic plan and in compliance with ICH guidelines. The various types of ADME, PK/TK, and DM studies, which include in vitro metabolism and delivery, animal and human pharmacokinetics, protein binding, mass balance, tissue distribution, metabolite isolation and identification, and toxicokinetic support, will be discussed. |
|
|
Upon completing this course, participants will have a basic knowledge of the research studies conducted to characterize the likelihood of success for a drug candidate (either a small organic molecule (NCE) or macromolecule) after administration to animal models and humans. |
|
|
|
No comments:
Post a Comment